Betaine analogues alter homocysteine metabolism in rats.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 15006639)

Published in Int J Biochem Cell Biol on May 01, 2004

Authors

Sandy Slow1, Michael Lever, Martin B Lee, Peter M George, Stephen T Chambers

Author Affiliations

1: Biochemistry Unit, Canterbury Health Laboratories, PO Box 151, Christchurch, New Zealand. sandy.slow@cdhb.govt.nz

Articles by these authors

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med (2009) 7.82

A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet (2011) 5.61

Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int (2010) 3.37

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int (2011) 3.05

Impact of routine systematic polymerase chain reaction testing on case finding for Legionnaires' disease: a pre-post comparison study. Clin Infect Dis (2013) 2.28

Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA (2012) 2.27

A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med (2011) 2.22

Use of ethanol locks to prevent recurrent central line sepsis. J Infect (2004) 1.69

Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine. Cardiovasc Drugs Ther (2009) 1.49

Peritonsillar infection in Christchurch 2006-2008: epidemiology and microbiology. N Z Med J (2011) 1.46

Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis. Br J Haematol (2007) 1.43

Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol (2003) 1.41

Prospective validation of cerebrospinal fluid bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem (2007) 1.40

Cutaneous myiasis due to Dermatobia hominis (the human botfly) in a New Zealand traveller returned from South America. N Z Med J (2009) 1.39

Rapid and simple high-performance liquid chromatographic assay for the determination of metformin in human plasma and breast milk. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.36

Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol (2008) 1.35

Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol (2007) 1.31

The scent of Mycobacterium tuberculosis--part II breath. Tuberculosis (Edinb) (2009) 1.27

Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories. N Z Med J (2002) 1.23

Contamination of Qiagen DNA extraction kits with Legionella DNA. J Clin Microbiol (2003) 1.22

Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons. Mol Cell Neurosci (2003) 1.21

Cystatin C--a paradigm of evidence based laboratory medicine. Clin Biochem Rev (2008) 1.17

Recurrent breast abscess caused by Gordonia bronchialis in an immunocompetent patient. J Clin Microbiol (2005) 1.17

Double complex mutations involving F8 and FUNDC2 caused by distinct break-induced replication. Hum Mutat (2007) 1.15

Trimethylaminuria: causes and diagnosis of a socially distressing condition. Clin Biochem Rev (2011) 1.12

Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease. Am J Pathol (2006) 1.09

The scent of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2008) 1.08

Detection of factor VIII gene mutations by high-resolution melting analysis. Clin Chem (2007) 1.08

The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men. Ann Clin Biochem (2012) 1.06

Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol (2008) 1.06

2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung. BMC Pulm Med (2010) 1.05

Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis. Pharmacogenet Genomics (2005) 1.05

Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa. Atherosclerosis (2007) 1.02

Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy. Thorax (2013) 1.00

DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest (2014) 0.97

Plasma lipids and betaine are related in an acute coronary syndrome cohort. PLoS One (2011) 0.97

Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic. Metabolism (2005) 0.96

Coenzyme Q10: is there a clinical role and a case for measurement? Clin Biochem Rev (2008) 0.95

Novel fibrinogen gamma375 Arg-->Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology (2002) 0.94

A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment. Hum Mutat (2009) 0.93

Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes. J Infect (2009) 0.93

Effects of orange juice and proline betaine on glycine betaine and homocysteine in healthy male subjects. Eur J Nutr (2007) 0.93

Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects. Am J Clin Nutr (2008) 0.92

Proteome-wide analysis and CXCL4 in systemic sclerosis. N Engl J Med (2014) 0.92

Use of fully denaturing HPLC for UGT1A1 genotyping in Gilbert syndrome. Clin Chem (2005) 0.92

Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity. Pharmacogenet Genomics (2008) 0.90

Short and long-term variation of plasma glycine betaine concentrations in humans. Clin Biochem (2004) 0.90

Betaine and secondary events in an acute coronary syndrome cohort. PLoS One (2012) 0.90

Successful antimicrobial therapy and implant retention for streptococcal infection of prosthetic joints. ANZ J Surg (2004) 0.88

Free and total cefazolin plasma and interstitial fluid concentrations at steady state during continuous infusion. J Antimicrob Chemother (2002) 0.88

Benefits of knowledge-based interprofessional communication skills training in medical undergraduate education. JRSM Short Rep (2011) 0.88

Protein binding of cefazolin is saturable in vivo both between and within patients. Br J Clin Pharmacol (2007) 0.87

Inter- and intra-individual variations in normal urinary glycine betaine excretion. Clin Biochem (2007) 0.87

Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults. PLoS One (2013) 0.87

Separation of cationic aracyl derivatives of betaines and related compounds. J Chromatogr A (2005) 0.87

Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. Kidney Int (2002) 0.87

Functional rescue of mutant ABCA1 proteins by sodium 4-phenylbutyrate. J Lipid Res (2012) 0.87

Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate. Clin Diagn Lab Immunol (2005) 0.86

Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure. Eur J Heart Fail (2008) 0.86

Evaluation of high-resolution melting analysis for screening the LDL receptor gene. Clin Biochem (2008) 0.86

Campylobacter fetus-associated epidural abscess and bacteremia. J Clin Microbiol (2009) 0.86

Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound. Ann Am Thorac Soc (2014) 0.85

Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study. Cardiovasc Diabetol (2012) 0.84

Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. Atherosclerosis (2004) 0.84

Biological variation of coenzyme Q10. Clin Chem (2005) 0.83

Plasma and urine betaine and dimethylglycine variation in healthy young male subjects. Clin Biochem (2009) 0.83

Measurement of marine osmolytes in mammalian serum by liquid chromatography-tandem mass spectrometry. Anal Biochem (2011) 0.82

Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort. Hum Mutat (2002) 0.82

Plasma total coenzyme Q9 (CoQ9) in the New Zealand population: reference interval and biological variation. Clin Chem (2007) 0.82

Coenzyme Q10; an adjunctive therapy for congestive heart failure? N Z Med J (2009) 0.82

Real-time detection of common microbial volatile organic compounds from medically important fungi by Selected Ion Flow Tube-Mass Spectrometry (SIFT-MS). J Microbiol Methods (2005) 0.82

Sex differences in the control of plasma concentrations and urinary excretion of glycine betaine in patients attending a lipid disorders clinic. Clin Biochem (2007) 0.82

The sialic acid content of fibrinogen decreases during pregnancy and increases in response to fibrate therapy. Thromb Res (2005) 0.82

A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome. Am J Hypertens (2011) 0.81

Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans. Thromb Haemost (2003) 0.81

An abnormal urinary excretion of glycine betaine may persist for years. Clin Biochem (2007) 0.81

Folate and vitamin B12 status of women of reproductive age living in Hanoi City and Hai Duong Province of Vietnam. Public Health Nutr (2008) 0.81

Role of genetic testing in retinoblastoma management at a tertiary referral centre. Clin Experiment Ophthalmol (2010) 0.81

The bioavailability of coenzyme Q10 supplements available in New Zealand differs markedly. N Z Med J (2004) 0.81